Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Rheumatol Int ; 31(3): 405-7, 2011 Mar.
Article in English | MEDLINE | ID: mdl-19834709

ABSTRACT

Macrophage activation syndrome (MAS) is a disorder characterized by increased activation of mononuclear cells leading to phagocytosis of blood cell precursors in the bone marrow. We describe a case of MAS triggered by disseminated histoplasmosis occurring in a patient with Still's disease on long-term treatment with adalimumab.


Subject(s)
Antibodies, Monoclonal/adverse effects , Antirheumatic Agents/adverse effects , Histoplasmosis/complications , Macrophage Activation Syndrome/etiology , Still's Disease, Adult-Onset/complications , Still's Disease, Adult-Onset/therapy , Adalimumab , Antibodies, Monoclonal, Humanized , Humans , Phagocytosis , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL